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Abstract: When cytoplasmic extracts of guinea-pig myenteric 
neurones are submitted to centrifugal density gradient frac- 
tionation in a zonal rotor acetylcholine is bimodally distrib- 
uted in the gradient, in a peak ( I )  rich in synaptic vesicles of 
the classic type and in a denser peak (II/VI) rich in dense- 
cored vesicles and vasoactive intestinal polypeptide (‘VIP). 
The putative stable synaptic vesicle markers synaptophysin 
(p38). vesicular proteoglycan, and Mg’+-activated ATPase 
were also bimodally distributed, with a peak coincident with 
peak I and another, broader peak embracing peak II/VI, and 
neighbouring peaks of other neuropeptides resolved from 
peak II/VI by the density gradient separation procedure used. 
To  establish whether the stable markers, acetylcholine and 
VIP in peak II/VI were present in one particle or several, 
attempts were made to separate them by particle-exclusion 
chromatography and differential osmotic fragility. These were 
unsuccessful, leading us to conclude that the storage particles 
in peak II/VI contain both neurotransmitters and all three 
putative stable synaptic vesicle markers. It is suggested that 
such particles are the counterparts, in cholinergic neurones 
of the myenteric plexus, of the dense-cored, enkephalin- and 
noradrenaline-containing vesicles of certain adrenergic neu- 
rones and, like the latter, may exist in a precursor-product 
relationship with the classic synaptic vesicles containing the 
small-molecular-mass transmitters and found in the same 
nerve terminals. Key Words: Myenteric neurones-char- 
acterization of storage particles rich in acetylcholine and va- 
soactive intestinal polypeptide-Synaptophysin-Vesicle- 
specific proteoglycan-MgATPase. Agoston D. V. and 
Whittaker V. P. Characterization, by size, density, osmotic 
fragility, and immunoaffinity, of acetylcholine- and vasoactive 
intestinal polypeptide-containing storage particles from 
myenteric neurones of the guinea-pig. J.  Neurochem. 52, 
1474- I480 ( 1989). 
In a previous article (Agoston et al., 19858) we ob- 
served that homogenates of the myenteric plexus-lon- 
gitudinal muscle (MPLM) preparation of guinea-pig 
ileum prepared under conditions of relatively mild liq- 
uid shear (“protective homogenization,” PH) contained 
acetylcholine (ACh)-rich synaptic vesicles and stolrage 
particles for substance P (SP), somatostatin (SS), and 
vasoactive intestinal polypeptide (VIP), all of which 
could be separated from each other by high-resolution 
centrifugal density-gradient separation on a zonal rotor. 
The peaks containing the neuroactive substances were 
designated I (synaptic vesicles), IV (SP), V (SS), and 
VI (VIP). In recent work (D. V. Agoston and C. Shaw, 
in preparation) the presence of a fifth peak, less dense 
than peak IV, and containing gastrin-releasing poly- 
peptide (GRP), has been identified. Interestingly, ACh 
was bimodally distributed in the gradient under PH 
conditions (which were also optimal for VIP-containing 
particles): in addition to its main peak in association 
with synaptic vesicles, it formed a second peak (11) 
which coincided with VIP. The main vesicular com- 
ponent in this peak (here designated II/VI) was dense 
cored, with a diameter of 1 10 nm. 
The main object of the present work was to deter- 
mine whether ACh and VIP in peak II/VI really were 
in the same storage particle or in separate particles. For 
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this, three tests of homogeneity were applied: attempts 
were made to separate the two activities in modified 
gradients, by particle exclusion chromatography, and 
varying degrees of hypoosmotic stress were applied in 
an effort to secure differential release. 
The distribution of three stable putative synaptic 
vesicle markers, Mg2+-activated ATPase (MgATPase; 
EC 3.6.1.3) (Breer et al., 1977), vesicular proteoglycan 
(PG) (Walker et al., 1983), and synaptophysin (p38) 
(SY) (Jahn et al., 1985; Wiedenmann and Franke, 
1985) in fractions from density gradients or particle 
exclusion chromatography was measured in an attempt 
to detect contamination of fractions containing VIP 
storage particles with synaptic vesicles. 
A preliminary account of this work has been given 
(Agoston, 1987). 
MATERIALS AND METHODS 
Fractionation of MPLM storage particles 
Isolation of storage particles by zonal density-gradient cen- 
trifugation. The procedure of Dowe et al. (1 980) and Agoston 
et al. (1985a,b) was followed with modifications. MPLM strips 
(8-10 g) were prepared from the ilea of six guinea-pigs of 
300-350 g body weight and placed in 0.16 M NaCl isotonic 
homogenization buffer at room temperature (20°C). The use 
of room temperature instead of ice-cold conditions prevented 
the cold-induced fusion of peptide-containing vesicles and 
so increased the yield. All solutions contained: 10 mM 
HEPES, pH 6.8; 1 mM EGTA, 0.1 mM EDTA; 0.1 mM 
phenylmethylsulphonyl fluoride (PMSF); the kallikrein in- 
hibitor aprotinin (Trasylol, Bayer), 100 U ml-'; 0.01 mM 
NaN3; 1 mM dithiothreitol. In some experiments NaN3 was 
replaced by 0.01 % thiomersal and 0.05% bacitracin was also 
included. The homogenization medium containing the iso- 
lated strips was replaced by 32-40 ml of cold medium (4°C) 
and homogenization was begun immediately. The strips were 
first minced with scissors for 5 min giving an approximately 
20% (wt/vol) tissue dispersion. This was further comminuted 
in a high speed Virtis blender at 45,000 rpm for two 10-s 
periods with a cooling interval. In some experiments Anti- 
foam (Sigma) was added before the comminution. This pre- 
homogenate was placed in a Teflon-glass homogenizer and 
10 passes were made at 800 rpm lasting for two 2-min periods 
with a cooling break. This final homogenate was centrifuged 
for 20 min at 1,000 g, at 4°C. The supernatant was decanted 
and the pellet and the pellicle were rehomogenized and re- 
centrifuged as described above. The combined supernatant 
was loaded onto a gradient formed in a 300-ml-capacity 
Beckman Ti-60 zonal rotor as previously described by Agos- 
ton et al. (1985a,b) or onto a more linear gradient formed 
using 1 .O M sucrose as the first dense solution and 1.6 M as 
the second; changeover was after 200 ml. Centrifugation for 
both conditions was at 60,000 rpm for 3 h. 
Particle exclusion chromatography. Peaks I and II/VI 
identified by their sucrose concentrations (peak I, 0.4-0.5 M 
sucrose; peak II/VI, 0.95-1.2 M sucrose) were pooled and 
chromatographed on a column of Sephacryl-1000 (Phar- 
macia) as described by Agoston et al. (1989). Such columns 
are capable of resolving synaptic vesicles from dense-cored 
vesicles derived from Torpedo electromotor neurones (Agos- 
ton et al., 1989) though the separation is not as effective as 
with density gradient centrifuging. Care was taken, by ad- 
justing the NaCl content of the NaCI-0.32 M sucrose that 
comprised the mobile phase, to ensure that the osmolarities 
of the mobile phase during chromatography were identical 
to those of the pooled fractions as determined by means of 
a Krauss osmometer. This precaution resulted in a better 
(50-65%) recovery, especially in the case of the peptide-con- 
taining vesicles. In some runs NaCl was replaced by the re- 
quired amount of glycine; however, glycine interfered with 
the leech bioassay so it was used in only a limited number 
of experiments. 
Columns (60 X 1 cm or 120 X 1 cm) of Sephacryl-1000 
(Pharmacia) were equilibrated at a flow rate of 20 ml h-' 
with degassed elution buffer containing: 0.32 M sucrose; the 
desired amount of NaCI; 10 mM HEPES buffer, pH 6.6 (at 
4OC); 1 mM EGTA; 0.1 mM EDTA; 0.3 mM PMSF 100 U 
ml-' Trasylol (Bayer); 0.01% t h i o m e d ,  1 mM dithiothreitol; 
and in some runs 0.05% bacitracin. After several bed volumes 
of wash the column was calibrated with 2-3 ml of Torpedo 
electromotor synaptic vesicles prepared according to our 
standard procedure (Ohsawa et al., 1979). The columns were 
then conditioned with a 100,000 g supernatant of the zonal 
parent fraction to reduce nonspecific adsorption of subcellular 
particles. Pooled fractions (4-8 ml) were applied for each run 
and 1 20-drop (approximately 4-ml) fractions were collected. 
All preparative procedures were carried out in a cold room 
at 4°C. 
Determination of osmotic fragility 
ACh- and VIP-containing fractions derived from zonal runs 
were pooled and samples were taken for transmitter and pro- 
tein determination. The pooled fractions were then aliquoted 
(usually 1 .O ml) and exposed to dialysis against large volumes 
(usually 2 L) of buffers with osmolarities reduced stepwise. 
The diaiysis buffer was identical to that of the sucrose gradient 
except in respect to sucrose concentration. As controls, pooled 
fractions were dialysed against a buffer with an osmolarity 
identical to that of the pooled fractions. The dialysis was 
carried out for 6 h in the cold (4°C). The osmolarities of the 
buffer present in the bags were determined at the end of the 
dialysis by freezing-point depression. The contents of the bags 
were then divided and their protein, ACh and VIP contents 
were determined. Results were expressed as the percentage 
of contents derived from control, isoosmotic samples. Also 
the volumes of each bag were measured after dialysis and 
dilution factors were calculated; all results have been corrected 
appropriately. 
Analytical methods 
Determination of neuroactive substances. ACh was mea- 
sured by bioassay on the dorsal muscle ofthe leech (Whittaker 
and Barker, 1972). Samples were acidified to pH 4.0 and 
stored at -20°C until assay. VIP was extracted from the frac- 
tions by bringing them to 95°C by the addition of 10 volumes 
of boiling distilled water, maintaining them at that temper- 
ature in a water bath for 5 min, cooling on ice and then 
adding acetic acid to a final concentration of 0.1 M. Samples 
were then lyophilized using a freeze drier equipped with a 
vacuum centrifuge. 
VIP was assayed as described using guinea-pig VIP as a 
standard (Agoston et al., 19891, 1988u,b). 
Enzyme determinations. MgATPase activity was deter- 
mined in the presence of oligomycin and ouabain as described 
by Agoston et al. (1989). P, was determined in protein-free 
supernatants according to Lanzetta et al. (1 979). In some P, 
determinations Triton X-100 (Sigma) replaced Flaminox 
(Fischer), giving identical sensitivity and stability. 
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Immunochemical procedures 
Sample preparation and dot assay of stable vesicle markers. 
Particles were pelleted from zonal or chromatographic frac- 
tions in a Beckman Airfuge using multiple runs and the pellets 
were treated as described by Jahn et al. (1985) and Agoston 
et al. (1986). Samples were dotted immediately onto nitro- 
cellulose paper (Bio-Rad, Munich, F.R.G.) or stored at -80°C 
in aliquots until assay. To exclude disproportionality due to 
interference or nonspecific binding 0.5, 1.0, and 2.0 p1 of 
samples were dotted. Experimental details and calculation of 
results are published elsewhere (Jahn et al., 1985; Agoston 
et al., 1986). 
Gel electrophoresis. Pellets were dissolved in sample buffer 
and separated electrophoretically on 10% polyacrylamide gels 
in the presence of sodium dodecyl sulphate (SDS-PAGE) in 
a mini-gel apparatus according to Laemmli (1 970); the sep- 
arated proteins were stained after the runs by a silver-staining 
procedure (for details see Agoston et al., 19856). The stained 
gels were dried onto Whatman filter paper in a Bio-R.ad ap- 
paratus and scanned in a Shimadzu densitometer. 
Immunoprecipitation of storage particles. Immunoprecip- 
itation was performed using the anti-synaptophysinl poly- 
clonal antibody R10 and an immunobead second antibody 
reagent (Bio-Rad) on pooled fractions derived from zonal 
separations. ACh- (peak I) and VIP- (peak II/VI) containing 
fractions were identified by their refractive indices and pooled. 
To prevent loss of transmitters during the immunoprecipi- 
tation procedure the osmolarity of the pooled fractions was 
maintained during the entire procedure by the addition of 
appropriate amounts of sucrose and NaCI. As a result of the 
increased density of the incubation medium the centiifuga- 
tion time was longer than recommended to ensure thie sed- 
imentation of the beads; this also resulted in a better sepa- 
ration of bound and free vesicles. The vesicle fractions con- 
tained: 0.1% bovine serum albumin; 1 mM EGTA; 0.02% 
NaN3; 100 U ml-' Trasylol (Bayer); 0.3 Msucrose; 1 0  mM 
Tris HC1, pH 7.4; and 0.16 M NaCl. The suspensions were 
incubated overnight at 4°C with gentle rotation. Second an- 
tibody-coated immunobeads were washed several times be- 
fore use with 0.16 M NaCl in 10 mM Na-phosphate huffer, 
pH 7.4, containing 0.02% NaN3. The vesicle fraction!; were 
incubated with freshly washed immunobeads for 2 h at room 
temperature. After sedimentation at 1,000 g for 10 niin in 
the cold, supernatants were removed, and the pellets, were 
processed for ACh and VIP assay. Several controls were used: 
(1) to test the efficacy of separation no immunobeads, were 
added; after decanting the supernatants the tubes were pro- 
cessed as above for transmitter assay; (2) the first antibody 
was replaced by control pooled rabbit sera; (3) to test the 
nonspecific binding capacity of immunobeads the first anti- 
serum was omitted. 
Immunoblot analysis of separated proteins. Gels were 
equilibrated after electrophoresis in an electrotransfer buffer 
of composition: 0.19 M glycine; 0.025 M Tris, pH 8.0; 20% 
(vol/vol) methanol for 30 min followed by electrophoretic 
transfer for 60 min at 4°C (Towbin et al., 1979). Following 
incubations with the first antibodies '251-labelled second an- 
tibody (anti-rabbit, affinity-purified Fab fragment, Amer- 
sham-Buchler, Braunschweig, F.R.G.) was applied. After 
washing and drying, the filters were exposed to Amersham 
Betamax x-ray film at -8OOC. 
Antibodies. The two cholinergic-specific anti-proteoglycan 
antisera of Walker et al. (1983) were used as previously de- 
scribed by Agoston et al. (1986). The three different anti- 
synaptophysin (p38) antibodies used in our experiments were 
as follows. R 10 polyclonal antibody, kindly provided by Dr. 
E. Floor and characterized by Buckley et al. (1987); this was 
used through the experiments. In some experiments the 
binding of two monoclonal antibodies was also tested: SY38,  
a kind gift from Dr B. Wiedenmann (Wiedenmann and 
Franke, 1985) and C 7.2, a small amount of which was made 
available through Mr. J. W. Hell with the kind approval of 
Dr. R. Jahn (Jahn et al., 1985). All gave similar results. 
Protein content offractions. Protein content was determined 
by the method of Peterson (1 977). 
RESULTS 
Fractionation of storage particles 
Density-gradient centrifugation. Figure 1 a shows the 
distribution of ACh and VIP in the type of gradient 
previously used (Agoston et al., 1986); the starting ma- 
terial was prepared by the modification of our original 
PH technique described in Materials and Methods. As 
before, particles containing VIP collect in a dense re- 
gion of the gradient (peak at 1.1 M sucrose) corre- 
sponding to peak VI of our earlier work: ACh is dis- 
tributed bimodally; its main peak (I) is as before at 0.4 
A4 sucrose and a second smaller peak (11) coincides 
with the single VIP peak at 1.1 Msucrose. The shoulder 
at 1.2 M sucrose observed in the VIP peak but not 
noted earlier was reproducible under our mild ho- 
Fraction No 
FIG. 1. Distribution (as a percentage of total recovered) of (a) ACh 
and VIP and (b) MgATPase, PG, and SY in a sucrose density gra- 
dient after centrifugal separation in a Beckman Ti-60 zonal rotor 
for 3 h at 60,000 rpm of a 30-ml sample of supernatant derived 
from 8-10 g of MPLM. The arrows in (b) indicate the positions in 
the gradient of the SP and VIP peaks. The dense peak of stable 
markers embraces both peptide peaks. The volume of each fraction 
was 5 ml. 
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mogenization conditions and may represent synapto- 
soma1 VIP since as we have previously shown (Dowe 
et al., 1980) the small number of synaptosomes gen- 
erated by homogenizing MPLM sediment to this den- 
sity. 
Figure 1 b shows the distribution of MgATPase ac- 
tivity and PG and SY immunoreactivity. It will be seen 
that the distribution of these three stable vesicle markers 
is almost identical and is also bimodal with a peak 
coincident with the ACh-rich synaptic vesicle peak and 
a second peak overlapping peak II/VI. This suggests 
that these markers are common both to synaptic ves- 
icles and the larger dense-cored vesicles in the denser 
part of the gradient. The broadness of the dense peak 
in Fig. 1 b may be accounted for by assuming that these 
markers are present in all four storage particles that 
have been identified in this part of the gradient, those 
containing (in order of increasing density) GRP, SP, 
SS, and VIP. The arrows in Fig. l b  indicate the posi- 
tions of the SP and VIP peaks; both are embraced by 
the enzyme activity and the immunoreactivity. 
Figure 2 shows a similar experiment with a gradient 
profile selected to increase the resolution in the denser 
region of the gradient (0.8-1.4 M sucrose). The peaks 
of ACh (11) and VIP (VI) in the dense part of the gra- 
dient (Fig. 2a) are more spread out but remain coin- 
cident; the prominent shoulder of VIP remains and is 
L ,  
10 20 30 40 50 
Fraction No 
FIG. 2. An experiment similar to that shown in Fig. 1 but with a 
sucrose gradient that rose more steeply in its lighter region and 
less steeply in its denser. This had the effect of sharpening peak 
I and broadening peak II/VI. In spite of the increased resolution in 
this part of the gradient, there is no evidence for any separation 
of peaks II and VI. a: ACh and VIP. b MgATPase, PG, and SY. 
Fraction volume as in Fig. 1. 
a Torpedo electromotor 







FIG. 3. Distribution of (a) ACh, VIP, and protein and (b) MgATPase, 
PG, and SY in the effluent from a 60 X 1 cm column of Sephacryl- 
1000 after loading with 4 ml of peak II/VI. Some aggregated material 
came through in the void volume, but most of the ACh, VIP, 
MgATPase, PG, and SY emerged as a single peak with a smaller 
retention volume than either myenteric (peak I) or Torpedo elec- 
tromotor (arrow) synaptic vesicles; thus the column failed to resolve 
peak II from peak VI. The final protein peak is one of soluble protein. 
Note that as the distribution of each component is expressed as 
percentage of total recovered component, and there is only one 
main peak, the degree of coincidence of ACh, MgATPase. PG, 
and SY with VIP is greater than in Figs. 1 and 2 where these four 
components (but not VIP) are bimodally distributed. 
also broadened. Corresponding changes take place in 
the distribution of the stable vesicle markers. However, 
it is now seen that whereas the dense peaks of MgATP 
and SY retain their broad configuration, the distribu- 
tion of PG more closely approximates to that of ACh 
and VIP. 
Particle-exclusion chromatography. In these exper- 
iments possible differences in particle size rather than 
density were exploited in an effort to separate ACh 
from VIP. Sephacryl- 1000 columns gave better results 
than columns of CPG-3000 B porous glass beads sup- 
plied by Electronucleotide; columns of beads provided 
by two other companies had insufficient resolution. 
As seen in Fig. 3, chromatography of peak II/VI 
failed to separate ACh from VIP or from the stable 
vesicle markers; all components had an identical re- 
tention volume which was appreciably less than that 
of ACh in peak I or electromotor synaptic vesicles 
(arrow). 
Immunoprecipitation. Because SY and PG were 
originally considered to be synaptic-vesicle specific, a 
polyclonal antibody to SY kindly provided by Dr. E. 
Floor and an immobilized second antibody were tested 
for their ability to effect the immunoprecipitation of 
the VIP-containing particles of peak II/VI. As a control, 
the same technique was applied to the ACh of peak I. 
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TABLE 1. Immunoprecipitation ofpeaks I and VI by an anti-SY antiserum (R 10) 
Parameter Units 
~~ 
Peak I Peak VI 
How determined (ACh) (VIP) 
Total sedimentable activity Percentage of tolal activity Centrifuging at 180,000 87 f 3 76 f 7 
g for 1 h 
Nonspecific immunoprecipitable activity Percentage of sedimentable activity Immune serum omitted 19 f 3 21 f 4 
Specific immunoprecipitable activity Percentage of sedimentable activity after deduction Complete system 4 8 + 6  3 3 k 5  
of nonsuecific immunoureciuitable activity Dresent 
Values are means f SEM of four experiments. 
Table 1 shows that the ACh of peak I and the VIP 
of peak II/VI are both precipitated in approxirnately 
the same proportions though the procedure was slightly 
less effective in immunoprecipitating VIP than ACh. 
This would be expected if the abundance of SY in the 
particles of peak VI were lower than that of peak I 
synaptic vesicles, or if its affinity for the antiserum were 
lower. However, the difference in behaviour was judged 
to be too small to make immunoprecipitation a1 valid 
test of the homogeneity of the VIP- and ACh-storage 
particles in peak II/VI. 
Osmotic fragility of storage particles 
Figure 4 shows the release, as a result of exposure 
to hypoosmotic conditions, of ACh from synaptnc ves- 
icles (filled circles) and from the material in peak 11/ 
VI (open triangles), also that of VIP (filled triangles) 
from peak II/VI. It will be seen that the particles storing 
ACh and VIP in peak II/VI cannot be distinguished 
in osmotic fragility from each other, but are signifi- 
cantly more fragile than synaptic vesicles with their 
greater surface area-to-volume ratio. 
I I 
0 1 5 0  300 
O L L  
Osmolallty (mOsM) 
FIG. 4. Osmotic fragility of (dashed line) the synaptic vesicles of 
peak I and of (continuous line) the particles of peak II/VI as mea- 
sured by the release of ACh (filled circles and open triangles) and 
by VIP (filled triangles). Points and bars are means f SEM of four 
experiments. 
Protein composition of the two types of 
storage particle 
Figure 5 shows the separation, by one-dimensional 
SDS-PAGE, of the proteins of (left) the synaptic vesicles 
in peak I and (right) the particles in peak II/VI. Al- 
though the patterns are different, many common com- 
ponents are present, as well as the contaminants actin 
(A) and myosin (M) derived from the longitudinal 
muscle of the preparation. To the left of each gel is the 
result of immunostaining a “blot” of the gel with anti- 
SY antiserum. In both gels a component of the expected 
mobility stains (arrows). If the staining pattern had been 
identical one might have argued that the presence of 
SY in the dense fraction was due to adsorbed, contam- 
inating vesicles. However, the main SY component in 
the dense vesicle preparation has a slightly lower elec- 
trophoretic mobility, but not so low as to suggest pro- 
teolytic breakdown (Rehm et al., 1986). 
DISCUSSION 
The results presented here show that the particles 
rich in ACh and VIP that were recovered in peak 11/ 
VI after centrifugal density gradient separation in a 
zonal rotor of a cytoplasmic extract of MPLM cannot 
be separated by further fractionation depending on pu- 
tative differences in density or size; further, they have 
identical osmotic fragilities and are both more osmot- 
ically fragile than the ACh-rich synaptic vesicles re- 
covered in a less dense region of the gradient. The sim- 
plest explanation of these results is that the two neu- 
roactive substances are indeed packaged in the same, 
large dense-cored particle previously shown to accu- 
mulate in this region of the gradient and that the pres- 
ence of ACh is not accounted for by contaminating 
synaptic vesicles. 
A consequence of this interpretation of the data is 
that the putative synaptic vesicle markers MgATPase, 
PG, and SY can no longer be regarded as synaptic ves- 
icle specific. The immunoblot shown in Fig. 5 shows 
that the SY immunoreactivity of the particles of peak 
II/VI differs slightly in electrophoretic migration from 
that of peak I, indicating that a substantial fraction of 
the SY of dense, neuropeptide-containing granules may 
be of somewhat lower molecular mass than that in syn- 
aptic vesicles, though bearing a common epitope. Our 
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FIG. 5. One-dimensional SDS-PAGE and immunoblot of proteins 
of peak II/VI (upper block) and peak I (lower block) particulate 
material. In both blocks the central figure is the silver-stained gel; 
above is the densitometric scan and below the immunoblot. These 
indicate the presence of SY immunoreactivity in both peaks (ar- 
rows); the lower apparent molecular mass of the main immuno- 
reactive band of peak II/VI material compared to that of peak I 
may indicate different extents of glycosylation of the SYs of the 
two particle types. A and M indicate actin and myosin, respectively. 
experiments do not however allow us to draw conclu- 
sions about the relative abundance and affinity for an- 
tibodies of SY immunoreactivity in synaptic vesicles 
and dense vesicles. If SY is involved in exocytosis as 
some authors have suggested, it seems reasonable to 
expect its occurrence in any subcellular particle capable 
of undergoing exocytosis. 
Our fractionation techniques do not allow us to 
conclude whether ACh-rich synaptic vesicles and dense 
vesicles containing both VIP and ACh coexist in the 
same terminals or not. However, it is tempting to be- 
lieve that here we are dealing with no epiphenomenon, 
such as the uptake of ACh in response to the existence 
of an outwardly directed proton gradient established 
for other purposes (e.g., for the processing of a neu- 
ropeptide by a proton-activated cathepsin) but the 
physiologically significant counterpart in the cholin- 
ergic system of the occurrence, in adrenergic terminals, 
of two classes of noradrenaline storage particle, possibly 
existing in a precursor-product relationship (Geffen 
and Livett, 1971; Lowe et al., 1988): a large, dense- 
cored vesicle containing the neuropeptide enkephalin 
as well as noradrenaline, and an electron-lucent syn- 
aptic vesicle containing the low-molecular-mass trans- 
mitter alone. Here there has long been evidence for 
the view that the form of noradrenaline storage granule 
which is synthesized in the perikarya and transported 
down the axon is the neuropeptide-containing, dense- 
cored vesicle; at the terminal this undergoes exocytosis 
and its membrane, having parted company with neu- 
ropeptide and electron-dense core material alike, is re- 
trieved as a synaptic vesicle capable of repeatedly un- 
dergoing cycles of noradrenaline uptake, exocytotic 
noradrenaline release, and endocytotic recovery as still 
functioning vesicles (for critical reviews see Lager- 
crantz, 1976, and Thureson-Klein, 1983). Might not 
the synaptic vesicles of fraction I, which are known to 
recycle (Agoston et al., 1985a), and the dense particles 
of fraction II/VI exist, within cholinergic neurones of 
the myenteric plexus, in a similar product-precursor 
relationship? 
In a recent article (Agoston et al., 1988b) we have 
shown that VIP is preferentially released from MPLM 
strips by high-frequency stimulation and that this re- 
lease is inhibited by the axonal transport blocker col- 
chicine, whereas ACh is preferentially released in a col- 
chicine-insensitive manner at low rates of stimulation. 
We postulated different intracellular mechanisms for 
the two release processes and this has been supported 
by other experiments (D. V. Agoston and J. Lisziewicz, 
submitted) in which different types of voltage-sensitive 
Ca2+ channels have been shown to be activated at high 
and low frequencies. However, these findings are not 
incompatible with the hypothesis that peak II/VI ves- 
icles are the precursors of peak I vesicles, because the 
colchicine insensitivity of our low-frequency ACh re- 
lease was tested only over a relatively short (-60 min) 
period. Clearly pulse-chase labelling of a stable dense- 
cored vesicle component will be needed to settle this. 
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